GRN and prostate cancer: An association between increased GP88 protein expression and a poor prognosis has been reported for breast cancer, ovarian cancer, non-small cell lung carcinoma, lymphomas, esophageal cancer, prostate cancer, and colorectal cancer [25,26,28,29,30,31,32].